Clinical Trial Update: Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, pharmacodynamics, and pharmacokinetics of various dosing regimens of MK-8266 in adults with hypertension; results completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MK-8266

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2019-02-28